MyoKardia
Why Robinhood?
You can watch MyoKardia and buy or sell other stocks, ETFs, and their options commission-free!About MYOK
MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM).
MYOK Key Statistics
Stock Snapshot
The current MyoKardia(MYOK) stock price is $224.91, with a market capitalization of 11.99B. The stock trades at a price-to-earnings (P/E) ratio of -39.87.
On 2026-02-20, MyoKardia(MYOK) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.31M.
The stock's 52-week range extends from a low of $42.65 to a high of $225.00.
The stock's 52-week range extends from a low of $42.65 to a high of $225.00.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.